Fort Belvoir, VANCT06854393Now EnrollingIRB Ready

Corneal Epithelial Wound Healing Clinical Trial in Fort Belvoir, VA

Access cutting-edge corneal epithelial wound healing treatment through this phase 2 clinical trial at a research site in Fort Belvoir. Study-provided care at no cost to qualified participants.

Sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine

Quick Self-Assessment

See if you qualify for this Fort Belvoir location

Preparing your pre-screening questions…

Expert Care in Fort Belvoir

Access corneal epithelial wound healing specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related corneal epithelial wound healing treatment provided free

Apply for This Fort Belvoir Location

Check if you qualify for this corneal epithelial wound healing clinical trial in Fort Belvoir, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fort Belvoir

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fort Belvoir site if eligible
  4. 4Begin participation

About This Corneal Epithelial Wound Healing Study in Fort Belvoir

The objective of this study is to evaluate the safety and effectiveness of Lacripep as a therapy for superficial corneal injury repair after Photorefractive keratectomy (PRK).

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Who Can Participate

Inclusion Criteria

Male or female, of any race, 21 years old and older
Active-duty U.S. military service members or their dependents eligible for care at Alexander T. Augusta Military Medical Center for 6-month period postoperatively
Desiring refractive correction of myopia up to -4.00 diopters (D) sphere with or without astigmatism 0 to -1.50 D and up to -4.00 D manifest spherical equivalent in both eyes
Stable refraction for the past year as demonstrated by a change in manifest refractive spherical equivalent of ≤ 0.50 diopters (D) in both eyes
CDVA of at least 20/20 in both eyes
Elected to undergo bilateral PRK
Able to meet follow up requirements for up to 6-month period post-operatively

Exclusion Criteria

Calculated ablation depth of greater than 75 microns or other conditions in either eye which in the judgement of the investigators will require use of prophylactic MMC
Signs of unstable or progressive myopia, keratoconus or keratoconus suspect in either eye
Abnormal corneal topographic findings in either eye e.g., keratoconus, pellucid marginal degeneration
Treatment targeted for monovision
Signs and symptoms of dry eye based on: (a) Corneal fluorescein staining total score ≥4 in the National Eye Institute (NEI)/Industry Workshop scale in either eye, (b) Anethetized Schirmer test score ≤5 mm/5 minutes in either eye, (c) Symptom score ≤40 using the Symptom Assessment in Dry Eye (SANDE) questionnaire in either eye
Female subjects who are pregnant, breastfeeding or intend to become pregnant during the study. Pregnancy and breastfeeding are contraindications to refractive surgery in general, including PRK, whether participating in this study or not.
Residual, recurrent or active ocular diseases or corneal abnormalities in either eye such as iritis, uveitis, keratoconjunctivitis sicca, herpetic keratitis, vernal conjunctivitis, lagophthalmos, corneal scarring, anterior basement membrane disease, recurrent erosions, glaucoma, previous steroid responder, occludable chamber angles, visually significant cataracts
Previous corneal or intraocular surgery in either eye for refractive or therapeutic purposes
Concurrent topical or systemic medications that may impair healing, including corticosteroids, antimetabolites, isotretinoin (Accutane®), amiodarone hydrochloride (Cordarone®) and/or sumatriptan (Imitrex®) (other medications in the same family as Imitrex will still be allowed)
Medical condition(s), which, in the judgment of the investigator, may impair healing, including but not limited to collagen vascular disease, autoimmune disease, immunodeficiency diseases, and ocular herpes zoster or simplex.
Individuals not legally competent to provide informed consent (e.g., incapacitated individuals, cognitively impaired) will not be enrolled. All subjects must provide consent to participate in the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fort Belvoir?

Yes, this clinical trial (NCT06854393) has an active research site in Fort Belvoir, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Corneal Epithelial Wound Healing Treatment Options in Fort Belvoir, VA

If you're searching for corneal epithelial wound healing treatment options in Fort Belvoir, VA, this clinical trial (NCT06854393) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fort Belvoir research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced corneal epithelial wound healing specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all corneal epithelial wound healing clinical trials near you to find additional studies recruiting in your area.

More Wound Healing Trials in Fort Belvoir, VA

See all wound healing clinical trials recruiting in Fort Belvoir — not just this study.

Browse Wound Healing Trials in Fort Belvoir →

Browse More Trials by Condition

Wound Healing TrialsAll Conditions →

Ready to Join in Fort Belvoir?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fort Belvoir, VA